Humana (NYSE:HUM) Trading Up 8.3% – Here’s Why

Humana Inc. (NYSE:HUM) shares were up 8.3% during trading on Tuesday . The company traded as high as $295.19 and last traded at $297.0720. Approximately 1,882,361 shares were traded during trading, a decline of 6% from the average daily volume of 1,992,616 shares. The stock had previously closed at $274.26.

Analyst Ratings Changes

Several research firms have recently commented on HUM. Leerink Partners upped their price target on shares of Humana from $185.00 to $255.00 and gave the stock a “market perform” rating in a research report on Thursday, April 30th. JPMorgan Chase & Co. boosted their target price on shares of Humana from $180.00 to $214.00 and gave the company a “neutral” rating in a research note on Friday, May 1st. Weiss Ratings restated a “sell (d+)” rating on shares of Humana in a research report on Tuesday, April 21st. Wolfe Research dropped their price target on shares of Humana from $325.00 to $250.00 and set an “outperform” rating on the stock in a research note on Monday, April 6th. Finally, Oppenheimer reiterated an “outperform” rating and set a $260.00 price objective on shares of Humana in a research report on Thursday, April 30th. Seven equities research analysts have rated the stock with a Buy rating, fifteen have assigned a Hold rating and four have given a Sell rating to the stock. According to data from MarketBeat, the company currently has a consensus rating of “Hold” and an average target price of $246.83.

Humana Price Performance

The business has a 50-day simple moving average of $202.73 and a two-hundred day simple moving average of $226.49. The company has a quick ratio of 1.77, a current ratio of 1.77 and a debt-to-equity ratio of 0.66. The stock has a market capitalization of $36.08 billion, a price-to-earnings ratio of 32.14, a P/E/G ratio of 2.82 and a beta of 0.68.

Humana (NYSE:HUM) last posted its quarterly earnings data on Wednesday, April 29th. The insurance provider reported $10.31 EPS for the quarter, topping analysts’ consensus estimates of $9.97 by $0.34. Humana had a return on equity of 10.45% and a net margin of 0.82%.The company had revenue of $39.65 billion for the quarter, compared to the consensus estimate of $39.37 billion. During the same quarter in the previous year, the business earned $11.58 EPS. The company’s quarterly revenue was up 23.5% compared to the same quarter last year. Humana has set its FY 2026 guidance at 9.000- EPS. As a group, research analysts predict that Humana Inc. will post 9.06 earnings per share for the current fiscal year.

Humana Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, July 31st. Stockholders of record on Friday, June 26th will be given a dividend of $0.885 per share. The ex-dividend date is Friday, June 26th. This represents a $3.54 annualized dividend and a dividend yield of 1.2%. Humana’s dividend payout ratio (DPR) is 37.86%.

Insider Activity

In other Humana news, insider Sanjay K. Shetty bought 810 shares of the company’s stock in a transaction that occurred on Monday, February 23rd. The shares were acquired at an average cost of $185.21 per share, for a total transaction of $150,020.10. Following the acquisition, the insider directly owned 11,657 shares of the company’s stock, valued at $2,158,992.97. This trade represents a 7.47% increase in their ownership of the stock. The purchase was disclosed in a document filed with the SEC, which is available through this link. 0.20% of the stock is owned by corporate insiders.

Institutional Inflows and Outflows

Several hedge funds have recently added to or reduced their stakes in HUM. Montag A & Associates Inc. boosted its stake in shares of Humana by 1,880.0% during the 4th quarter. Montag A & Associates Inc. now owns 99 shares of the insurance provider’s stock worth $25,000 after acquiring an additional 94 shares in the last quarter. CoreCap Advisors LLC lifted its stake in Humana by 54.4% during the fourth quarter. CoreCap Advisors LLC now owns 105 shares of the insurance provider’s stock valued at $27,000 after buying an additional 37 shares in the last quarter. Fideuram Asset Management Ireland dac acquired a new position in shares of Humana in the fourth quarter worth about $27,000. Reflection Asset Management purchased a new position in shares of Humana in the fourth quarter worth approximately $29,000. Finally, Rosenberg Matthew Hamilton lifted its position in shares of Humana by 136.0% in the 4th quarter. Rosenberg Matthew Hamilton now owns 118 shares of the insurance provider’s stock valued at $30,000 after acquiring an additional 68 shares in the last quarter. Institutional investors and hedge funds own 92.38% of the company’s stock.

Humana Company Profile

Humana Inc (NYSE: HUM) is a health insurance company headquartered in Louisville, Kentucky, that primarily serves individuals and groups across the United States. The company is best known for its Medicare business, offering Medicare Advantage plans and prescription drug (Part D) coverage, alongside a range of commercial and employer-sponsored group health plans. Humana’s products are designed to cover medical, behavioral health and pharmacy needs for members, with particular emphasis on seniors and Medicare-eligible populations.

In addition to traditional insurance products, Humana provides care-management and wellness services intended to support chronic-condition management, preventive care and care coordination.